Regulation of antioxidants in cancer.
NRF2
ROS
antioxidants
cancer
glutathione
oxidative stress
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
18 Nov 2023
18 Nov 2023
Historique:
received:
18
08
2023
revised:
19
10
2023
accepted:
01
11
2023
medline:
30
11
2023
pubmed:
30
11
2023
entrez:
29
11
2023
Statut:
aheadofprint
Résumé
Scientists in this field often joke, "If you don't have a mechanism, say it's ROS." Seemingly connected to every biological process ever described, reactive oxygen species (ROS) have numerous pleiotropic roles in physiology and disease. In some contexts, ROS act as secondary messengers, controlling a variety of signaling cascades. In other scenarios, they initiate damage to macromolecules. Finally, in their worst form, ROS are deadly to cells and surrounding tissues. A set of molecules with detoxifying abilities, termed antioxidants, is the direct counterpart to ROS. Notably, antioxidants exist in the public domain, touted as a "cure-all" for diseases. Research has disproved many of these claims and, in some cases, shown the opposite. Of all the diseases, cancer stands out in its paradoxical relationship with antioxidants. Although the field has made numerous strides in understanding the roles of antioxidants in cancer, many questions remain.
Identifiants
pubmed: 38029751
pii: S1097-2765(23)00917-6
doi: 10.1016/j.molcel.2023.11.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests I.S.H. reports financial support from Kojin Therapeutics and consulting fees for Ono Pharma USA. Funding and fees from these companies are outside the scope of the current work.